BridgeMD
New treatment option for Panic Disorder
Official title Qigong and Multicomponent Exercise in Panic Disorder
ClinicalTrials.gov ID: NCT07439224
What this study is testing
- What it's testing
- Panic disorder is a psychiatric disease characterized by recurrent panic attacks that occur in expected or unexpected situations and create feelings of intense fear, restlessness and discomfort. Panic disorder often has a chronic course, its frequency and severity can be irregular, various physical, mental, and behavioral symptoms can develop, and the quality of life of individuals can decrease significantly.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Being between the ages of 18-65
- Being diagnosed with "panic disorder" by a psychiatrist
- Not having another psychiatric illness
- Wanting to participate in the research voluntarily and signing the informed consent
- Not having a history of communication or neuromusculoskeletal disease that would not allow the application of evaluation and treatment methods
You likely can't join if
- Having a vision and/or hearing problem that would prevent participation in the study
- History of neurological, cardiopulmonary and musculoskeletal system disease that would negatively affect participation in evaluation and treatment
The study team makes the final eligibility decision.
Where it's taking place
- Izmir, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Izmir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.